Prosecution Insights
Last updated: November 20, 2026

Caroline Monserrat Lara, USPTO Patent Examiner

Listed by the USPTO as LARA, CAROLINE MONSERRAT

Tech Center 1600 • Art Units: 1633 1636 1651 1657 1658

This examiner grants 89% of resolved cases

Analysis

LARA, CAROLINE MONSERRAT examines in Tech Center 1600 and Art Unit 1633. The profile contains 9 resolved cases, an 88.9% allowance rate, and a median of 1083 days to allowance. The 14.3% interview lift indicates a positive association, but the limited resolved-case record calls for caution when using the result to predict an individual application.

Frequently represented companies include ModernaTX Inc., University of Florida Research Foundation Inc., and The Regents of the University of California. Listed firms are Troutman Pepper Locke LLP, BAUMGARTNER PATENT LAW, and Casimir Jones, S.C. Practitioners can use the profile for initial planning, while relying on the specific record for claim and interview decisions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

88.9%
Allow Rate
+28.9% vs TC avg
45
Total Applications
+14.3%
Interview Lift
1083
Avg Prosecution Days
Based on 9 resolved cases, 2023–2026

Rejection Statute Breakdown

3.0%
§101 Eligibility
22.0%
§102 Novelty
39.4%
§103 Obviousness
21.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18706176 AAV-MEDIATED THERAPIES FOR VISION LOSS ASSOCIATED WITH FRIEDREICH’S ATAXIA Non-Final OA University of Florida Research Foundation, Incorporated
18555508 PACKAGING CELLS WITH TARGETED GENE KNOCKOUTS THAT IMPROVE RETROVIRAL VECTOR TITERS Non-Final OA The Regents of the University of California
18841883 ENGINEERED IMMUNOMODULATORY ACCESSORY CELLS IMPROVE ALLOGENEIC ISLET TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION Non-Final OA CORNELL UNIVERSITY
18440260 EFFICIENT DIFFERENTIATION OF SECOND HEART FIELD CARDIAC PROGENITOR CELLS AND RIGHT VENTRICLE CARDIOMYOCYTES FROM HUMAN PLURIPOTENT STEM CELLS Non-Final OA Wisconsin Alumni Research Foundation
18854684 OXYGEN CARRIERS FOR MAINTAINING ORGAN VIABILITY DURING NORMOTHERMIC PERFUSION Non-Final OA Ohio State Innovation Foundation
18763564 HIGH-EFFICIENCY EXPRESSION VECTOR OF CIRCULAR RIBONUCLEIC ACID (circRNA) AND USE THEREOF Non-Final OA Zhejiang University
18583301 NUCLEIC ACID NANOPARTICLES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF Final Rejection IOWA STATE UNIVERSITY RESEARCH FOUNDATION INC.
18528348 GENERATING QUIESCENT HEPATIC STELLATE CELLS AND THEIR USE IN LIVER MODELS Non-Final OA The Cleveland Clinic Foundation
18842083 PROCESS TO ENHANCE VIRAL VECTOR PRODUCTION IN CELL-CULTURE USING GLYCYL-GLUTAMINE Non-Final OA Evonik Operations GmbH
18775133 Creation of Inducible Pluripotent Stem Cell Derived T Regulatory Cells by In Vitro Recapitulation ofThymic Development Non-Final OA CREATIVE MEDICAL TECHNOLOGIES, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Caroline Monserrat Lara's allowance rate?

88.9% of resolved applications examined by Caroline Monserrat Lara were allowed (9 resolved cases), compared with 34.9% across Art Unit 1633 over the last five years.

Does an interview help with examiner Caroline Monserrat Lara?

This examiner's interview lift is +14.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Caroline Monserrat Lara take to allow a patent?

Applications allowed by Caroline Monserrat Lara took 1,083 days on average from filing to allowance.

Which art unit does examiner Caroline Monserrat Lara work in?

Caroline Monserrat Lara examines applications in Art Unit 1633 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month